Press Release no. 06/2026

cBrain enters multi-year framework agreement with Deutsche Rentenversicherung Bund

Copenhagen, October 27, 2026

cBrain® (NASDAQ: CBRAIN) has entered into a framework agreement with Deutsche Rentenversicherung Bund (DRV Bund) for support and configuration services related to its existing F2-based digital audit case management solution (digitale Prüfdienstakte, DiPA). The agreement runs from November 1, 2026 through December 31, 2029.

For cBrain, the agreement marks an important continuation of its activities in Germany, currently the company’s largest international market.

About cBrain

cBrain® (NASDAQ: CBRAIN) is pioneering a new generation of integrated enterprise software, built specifically for government.

The cBrain F2 software brings together case management, document management, workflow automation, digital services and artificial intelligence in one unified platform. Delivered as commercial off-the-shelf (COTS) software, F2 enables government organizations to accelerate digital transformation without the complexity and cost of traditional custom-built IT systems.

F2 is used by more than 75 public authorities in Denmark, including the Danish government ministries.

Building on Denmark’s position as a global leader in digital government, cBrain is bringing the Danish model of digital government to the world. Today, F2 is used by government organizations across five continents, demonstrating how the Danish model can be reused and scaled internationally through standard software.

For more information, visit www.cbrain.com.

Best regards

Per Tejs Knudsen, CEO

Inquiries regarding this Press Release may be directed to 

Lars Møller Christiansen, CFO & Head of Investor Relations, cBrain A/S, ir@cbrain.com, +45 24429300

Attachment

MILAN, Oct. 27, 2026 (GLOBE NEWSWIRE) — Bending Spoons S.p.A. (“Bending Spoons”) today announced the proposed offerings of $1.5 billion (approximate equivalent) senior secured notes, subject to market and other conditions. The offerings are composed of $1 billion aggregate principal amount of U.S. dollar-denominated senior secured notes and $500 million (approximate equivalent) of euro-denominated senior secured notes (together, the “Notes”), both due in 2032.

The U.S. dollar-denominated Notes are proposed to be issued by Bending Spoons US Inc., a Delaware corporation, while the euro-denominated Notes are proposed to be issued by Bending Spoons Operations S.p.A., a joint stock company (società per azioni) organized under the laws of Italy. Each issuer is an indirect wholly owned subsidiary of Bending Spoons. Bending Spoons will not issue or guarantee the Notes.

The net proceeds from the offerings are intended to fund future acquisitions, to pay costs, fees, expenses, and taxes in connection with the offerings, and for other general corporate purposes. The interest rates, issue prices, and other terms of the Notes will be determined at pricing. There can be no assurance that the offerings will be completed on the terms described or at all.

This press release is being issued pursuant to Rule 135c under the Securities Act of 1933, as amended (the “Securities Act”). It does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other securities.

The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act, and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Notes and the related guarantees have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release are forward-looking statements. Forward-looking statements include statements about the proposed offering, including the expected use of proceeds. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “anticipate,” “aim,” “intend,” “plan,” “believe,” “estimate,” “potential,” “continue,” “foresee,” “forecast,” “in our view,” “probably,” “likely,” or other similar expressions.

Forward-looking statements reflect our current expectations and are based on assumptions and information available as of the date of this press release. Actual results and events may differ materially from those expressed or implied by such forward-looking statements due to a variety of risks and uncertainties, some of which are beyond our control. These include the risks and uncertainties described in the sections Risk factors and Management’s discussion and analysis of financial condition and results of operations in our registration statement on Form F-1, which is on file with the U.S. Securities and Exchange Commission and is available on our investor relations website at investors.bendingspoons.com and on the U.S. Securities and Exchange Commission website at www.sec.gov.

Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable law, we assume no obligation to update any forward-looking statements.

Contacts
Investors: investor-relations@bendingspoons.com
Media: press@bendingspoons.com 

GUANGZHOU, China, Oct. 27, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, was recently recognized for its AI-powered pharmaceutical procurement and inventory management platform, which was included in the 2026 Collection of Best Practices for High-Quality Pharmaceutical Distribution Development, highlighting the Company’s innovation in digital supply chain management.

Fangzhou’s AI-Powered Supply Chain Platform Recognized in 2026 for Pharmaceutical Distribution Best Practices

Fangzhou’s AI-Powered Supply Chain Platform Recognized in 2026 for Pharmaceutical Distribution Best Practices

The recognition was announced at the 10th Pharmaceutical Distribution Review and Certification Technology Conference in Guangzhou, organized by the Guangdong Food and Technology Association for Evaluation and Certification. The conference brought together industry experts, academics and business representatives to discuss regulatory compliance, sustainable development and technological innovation in pharmaceutical distribution.

The conference’s best practice showcase was established to identify and promote successful digital innovations across the pharmaceutical distribution industry.

Fangzhou’s “AI Algorithm-Based Pharmaceutical Procurement and Inventory Coordination Platform,” demonstrates the real-world impact of artificial intelligence for optimizing pharmaceutical procurement and inventory management. This industry validation underscores the Company’s efforts to improve supply chain efficiency through intelligent digital solutions, and offers actionable benchmarks for broader adoption across the pharmaceutical distribution sector.

Beyond supply chain innovation, Fangzhou has continued to advance its “AI + Chronic Disease Services” strategy, positioning itself as a full-lifecycle personal health service partner. The Company has integrated AI capabilities across patient services, physician support and operations management, aiming to improve the accessibility, continuity and efficiency of chronic disease care.

Powered by its proprietary “XingShi” Large Language Model (“XS LLM”), Fangzhou has developed AI applications tailored to a range of healthcare scenarios. Its AI Health Manager and AI Medication Assistant support patients with personalized health management and medication guidance, while AI pre-consultation tools and the AI Academic Assistant help physicians reduce repetitive workloads and improve service efficiency. The Company’s AI capabilities also extend to health monitoring, patient follow-up and health education.

This recognition builds on broader industry acclaim for Fangzhou’s digital healthcare innovations. Earlier this year, the Company’s “AI + Chronic Disease Services” solution was named to Fortune China’s Best Designs 2026 in recognition of innovative approach to addressing persistent challenges in long-term healthcare management.

Looking ahead, Fangzhou will continue strengthening its AI capabilities, refining its chronic disease service model and sharing practical experience in digital healthcare innovation with industry partners. The Company aims to support broader adoption of intelligent technologies across pharmaceutical distribution and healthcare services, contributing to the high-quality development of China’s healthcare industry.

About Fangzhou Inc.

Fangzhou Inc. (HKEX: 06086) is China’s leading online chronic disease management platform, serving 59.8 million registered users and 282,000 physicians (as of June 30, 2026). The Company specializes in delivering tailored medical care and AI‑enabled precision medicine solutions. For more information, visit https://investors.jianke.com.

Media Contact

For further inquiries or interview requests, please contact:

Xingwei Zhao
Director of Public Relations
Email: pr@jianke.com

Disclaimer: This press release contains forward‑looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e063f373-b862-4e4f-abfa-edce0393f11b

  • 70% in vivo editing of human APOC3 in a single administration
  • 76% triglyceride reduction after a single dose in murine disease model

NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment, today announced the presentation of preclinical data supporting .HEAL-101, its in vivo base editing product candidate targeting APOC3 for severe hypertriglyceridemia (sHTG), at the Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), being held October 27-30, 2026, in Hamburg, Germany.

.HEAL-101 is an APOC3-specific TALE base editor delivered as mRNA in liver-directed lipid nanoparticles (LNPs), designed to permanently inactivate APOC3, a genetically validated driver of elevated triglycerides, after a single intravenous administration. The poster presents an expanded preclinical data set for .HEAL-101, building on the initial dataset first disclosed by Cellectis on September 14, 2026.

“These expanded preclinical data reinforce the potential of our TALE base editing approach to achieve efficient and specific APOC3 editing following a single administration,” said Julien Valton, Ph.D., Vice President, Gene Therapy at Cellectis. “The substantial reduction in triglyceride level observed across our preclinical study provide further support for the development of .HEAL-101 as a potential one-time treatment for patients with severe hypertriglyceridemia.”

Key findings presented at ESGCT

  • Efficient and highly specific editing of APOC3 in vitro: In a human hepatic cell line, .HEAL-101 achieved a mean APOC3 editing rate of approximately 90%, without production of DNA double strand break at the target site.
  • Efficient editing of human APOC3 in vivo: In a normolipidemic humanized liver mouse model, a single intravenous injection of LNP-mRNA edited the human APOC3 gene at a mean rate of approximately 65%, reaching up to 70%.
  • Marked efficacy in a disease model: In a hyper triglyceridemic human APOC3 transgenic mouse model of hypertriglyceridemia, .HEAL-101 reduced APOC3 by 67% ± 12%, and triglycerides by 75% ± 11% (mean ± standard deviation).
  • Liver-restricted activity: Editing was detected in the liver, with no significant activity in the other tissues analyzed.

These preclinical results support the continued development of .HEAL-101. Cellectis plans to initiate a Phase 1 investigator-initiated trial (IIT) in China with preliminary clinical data expected in the second half of 2027.

Poster Information:

Title: In vivo editing of human APOC3 by TALE base editor normalizes triglyceride levels in animal models

Presenter: Julien Valton, Ph.D., Vice President Gene Therapy at Cellectis

Presentation date/time: Thursday, October 29 from 2 to 4 p.m. CET.

Poster number: P0208

The poster presentation is now available on Cellectis’ website.

About Cellectis

Cellectis is a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment. Leveraging decades of expertise in programmable DNA-binding proteins, the Company has built a differentiated genome engineering platform spanning gene editing, base editing, epigenetic editing and transcriptional regulation. By delivering the genomic intervention each disease requires, Cellectis is advancing a new generation of genetic medicines designed to move beyond disease management and toward lasting therapeutic impact. Cellectis’ headquarters are in Paris, France, with locations in New York and Raleigh (NC). Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker:ALCLS). To find out more, visit www.cellectis.com and follow Cellectis on LinkedIn and X.

Cautionary Statement
This press release contains “forward-looking” statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “designed to” , “expected” , “plan”, “potential”, or similar expressions and/or the negative of these. These forward-looking statements are based on our management’s current expectations and assumptions and on information currently available to management. Forward-looking statements in this press release include statements regarding the ability of the Company to initiate a IIT in China, the planned timing for the release of preliminary clinical data for the Company’s lead program, the potential of the Company’s preclinical candidate product based on pre-clinical results, the potential for success of the Company’s in vivo gene editing programs. Actual results, performance or events may differ materially from those projected in any forward-looking statement. Many important factors may adversely affect such forward-looking statements and cause actual results to differ from those in any forward-looking statement, including, without limitation, uncertainties inherent in the initiation and completion of preclinical and clinical studies; the availability and timing of results from studies, once initiated; the acceptance by global regulatory agencies of data generated from IIT in China; the potential that pre-clinical animal model data may not translate into further preclinical development or clinical setting; promising preclinical data not yielding positive further preclinical data or clinical results; the performance of the IIT in China, changes in the competitive landscape for in vivo gene editing products; expectations for regulatory approvals to conduct clinical trials; Furthermore, many other important factors, including those described in our Annual Report on Form 20-F as amended and in our annual financial report (including the management report) for the year ended December 31, 2025 and subsequent filings Cellectis makes with the Securities Exchange Commission from time to time, which are available on the SEC’s website at www.sec.gov, as well as other known and unknown risks and uncertainties may adversely affect such forward-looking statements and cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.

For further information on Cellectis, please contact:

Media contacts:
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com

Attachments

OP Corporate Bank plc
Interim Report 1 January–30 September 2026
Stock Exchange Release 27 October 2026 at 9.00 am EET

OP Corporate Bank plc’s Interim Report 1 January–30 September 2026

  • Operating profit decreased to EUR 388 million (442).
  • Total income grew by 2% to EUR 636 million (621). Net interest income grew by 7% to EUR 457 million (427). Investment income fell by 23% to EUR 79 million (103). Net commissions and fees grew by 28% to EUR 66 million (51). Other operating income decreased by 15% to EUR 34 million (41).
  • Impairment loss on receivables totalled EUR 19 million. A year ago, impairment loss on receivables reversed came to EUR 39 million. Non-performing exposures accounted for 1.4% (1.4) of total exposures.
  • Operating expenses increased by 5% to EUR 229 million (218). The cost/income ratio was 36% (35).
  • The loan portfolio grew by 10% to EUR 31.6 billion (28.7) year on year. The deposit portfolio increased by 2% year on year, to EUR 16.3 billion (16.1).
  • The Corporate Banking and Capital Markets segment’s operating profit decreased by 21% to EUR 212 million (268). Net interest income decreased by 8% to EUR 219 million (237). Impairment loss on receivables totalled EUR 3 million. A year ago, impairment loss on receivables reversed came to EUR 17 million. Net commissions and fees increased to EUR 17 million (4). Investment income decreased to EUR 74 million (97). Operating expenses increased by 6% to EUR 99 million (93). The cost/income ratio was 31% (27).
  • The Asset and Sales Finance Services and Payment Transfers segment’s operating profit decreased by 29% to EUR 108 million (152). Net interest income decreased by 14% to EUR 139 million (161). Impairment loss on receivables totalled EUR 5 million. A year ago, impairment loss on receivables reversed came to EUR 20 million. Net commissions and fees totalled EUR 43 million (43). Operating expenses totalled EUR 83 million (85). The cost/income ratio was 42% (39).
  • The Baltics segment’s operating profit decreased by 42% to EUR 17 million (29). Net interest income grew by 9% to EUR 50 million (46). Impairment loss on receivables totalled EUR 11 million. A year ago, impairment loss on receivables reversed came to EUR 2 million. Net commissions and fees totalled EUR 9 million (8). Operating expenses increased by 15% to EUR 32 million (28). The cost/income ratio was 53% (50).
  • The Group Functions segment’s operating profit was EUR 51 million (-7). OP Pohjola’s funding position and liquidity remained strong.
  • The CET1 ratio was 13.3% (14.1), which exceeds the minimum regulatory requirement by 4.4 percentage points.

OP Corporate Bank’s key figures and ratios

€ million Q1–3/2026 Q1–3/2025 Change, % Q1–4/2025
Operating profit (loss), € million 388 442 -12.2 559
Corporate Banking and Capital Markets 212 268 -20.8 343
Asset and Sales Finance Services and Payment Transfers 108 152 -29.4 184
Baltics 17 29 -41.9 38
Group Functions 51 -7 — -7
Total income 636 621 2.3 833
Total expenses -229 -218 4.8 -306
Cost/income ratio, %* 36.0 35.2 0.8 36.8
Return on equity (ROE), %* 7.8 9.4 -1.7 8.6
Return on assets (ROA), %* 0.5 0.6 -0.1 0.6
  30 Sep 2026 30 Sep 2025 Change, % 31 Dec 2025
CET1 ratio, %* 13.3 14.2 -0.8 14.1
Loan portfolio, € million 31,555 28,723 9.9 29,079
Guarantee portfolio, € million 2,888 2,712 6.5 2,662
Other exposures, € million** 7,171 5,262 36.3 5,579
Deposits, € million 16,309 16,060 1.5 16,987
Ratio of non-performing exposures to exposures, %* 1.4 1.3 0.1 1.4
Ratio of impairment loss on receivables to loan and guarantee portfolio, %* 0.07 -0.17 0.24 -0.10

Comparatives for the income statement items are based on the corresponding figures in 2025. Unless otherwise specified, figures from the end of 2025 are used as comparatives for balance-sheet and other cross-sectional items.
* Change in ratio, percentage point(s).
** Including loan commitments

Outlook

The Finnish economy is expected to grow faster in 2026 than in the previous year. Geopolitical uncertainty or the escalation of geopolitical crises may affect the capital markets and the economic environment of OP Pohjola and its customers.

A full-year earnings estimate for 2026 will only be provided for OP Pohjola, in OP Pohjola’s financial statements bulletin and in its interim and half-year financial reports.

The most significant uncertainties affecting OP Corporate Bank’s earnings performance relate to developments in the business environment, the capital market, and developments in impairment loss on receivables. Forward-looking statements expressing the management’s expectations, beliefs, estimates, forecasts, projections and assumptions are based on the current view on developments in the economy, and actual results may differ materially from those expressed in the forward-looking statements.

Financial reporting

Schedule for financial reports in 2026:

Financial Statements Bulletin for 1 January‒31 December 2026 10 February 2027
Report by the Board of Directors and Financial Statements 2026 Week 11, 2027
OP Corporate Bank plc’s Corporate Governance Statement 2026 Week 11, 2027

Schedule for financial reports for 2027:

Interim Report 1 January–31 March 2027 29 April 2027
Half-year Financial Report 1 January–30 June 2027 28 July 2027
Interim Report 1 January–30 September 2027 28 October 2027

Helsinki, 27 October 2026

OP Corporate Bank plc
Board of Directors

For additional information, please contact:

Katja Keitaanniemi, CEO, tel. +358 10 252 1387
Piia Kumpulainen, Chief Communications Officer, tel. +358 10 252 7317

DISTRIBUTION:
Nasdaq Helsinki Oy
Euronext Dublin (Irish Stock Exchange)
LSE London Stock Exchange
Major media
op.fi

OP Corporate Bank plc is part of OP Pohjola, Finland’s largest provider of financial services. OP Corporate Bank and OP Mortgage Bank are responsible for OP Pohjola’s funding in money and capital markets. As laid down in the applicable law, OP Corporate Bank, OP Mortgage Bank and their parent company OP Cooperative and other OP Pohjola member credit institutions are ultimately jointly and severally liable for each other’s debts and commitments. OP Corporate Bank acts as OP Pohjola’s central bank.

Vaisala Corporation        Interim Report January–September 2026        October 27, 2026, at 9:00 a.m. (EET)

Vaisala Corporation Interim Report January–September 2026: Excellent quarter with record-high profitability and orders received

This release is a summary of Vaisala’s Interim Report January–September 2026. The complete report is attached to this release as a pdf file. It is also available on the company website at https://www.vaisala.com/en/investors.

Third quarter 2026:        

  • Orders received EUR 164.6 (119.6) million, increase 38%, in constant currencies 37%
  • Order book at the end of the period EUR 215.0 (Dec 31, 2025: 185.8) million, increase 16%, in constant currencies 14%
  • Annual recurring revenue (ARR*) at the end of the period EUR 60.9 (Sep 30, 2025: 56.0) million, increase 9%
  • Net sales EUR 162.9 (154.0) million, increase 6%, in constant currencies 6%
  • EBITA EUR 40.6 (28.0) million, 24.9 (18.2) % of net sales
  • Operating result (EBIT) EUR 38.8 (25.7) million, 23.8 (16.7) % of net sales
  • Earnings per share EUR 0.80 (0.51)
  • Cash flow from operating activities EUR 35.6 (25.8) million

* As of Q1/2026, Vaisala reports annual recurring revenue (ARR) for the Xweather business area. ARR equals average recurring monthly revenue for the quarter multiplied by twelve, including charges from volume-based contracts.

January–September 2026:        

  • Orders received EUR 429.5 (365.2) million, increase 18%, in constant currencies 19%
  • Net sales EUR 451.4 (434.6) million, increase 4%, in constant currencies 6%
  • EBITA EUR 83.4 (68.0) million, 18.5 (15.7) % of net sales
  • Operating result (EBIT) EUR 77.8 (60.5) million, 17.2 (13.9) % of net sales
  • Earnings per share EUR 1.58 (1.14)
  • Cash flow from operating activities EUR 84.4 (58.9) million

Business outlook for 2026 – updated on October 12, 2026

Vaisala estimates that its full-year 2026 net sales will be in the range of EUR 610–630 million and its EBITA will be in the range of EUR 110–120 million. The business outlook excludes impacts of the planned Atmo, Inc. acquisition and potential significant changes in market conditions.

Earlier, Vaisala estimated, excluding potential significant changes in market conditions, that its full-year 2026 net sales will be in the range of EUR 600–630 million and its EBITA will be in the range of EUR 95–110 million.

Market outlook for 2026

Industrial markets are expected to grow, driven especially by the data center and semiconductor industries. Life science and power markets are expected to grow as well.

Mature meteorology and aviation markets normalized during 2025 after two years of exceptionally high demand. These markets are now expected to remain stable compared to the 2025 year-end levels.

Renewable energy markets are expected to decline.

Markets for Xweather subscription sales are expected to grow.

Key figures

MEUR 7-9/2026 7-9/2025 Change 1-9/2026 1-9/2025 Change 1-12/2025
Orders received 164.6 119.6 38% 429.5 365.2 18% 517.2
Order book. at the end of the period 215.0 180.4 19% 215.0 180.4 19% 185.8
Annual recurring revenue (ARR), at the end of the period 60.9 56.0 9% 60.9 56.0 9% 57.1
Net sales 162.9 154.0 6% 451.4 434.6 4% 596.9
Gross profit 100.2 83.9 20% 265.7 240.6 10% 329.7
Gross margin, % 61.5 54.4   58.9 55.4   55.2
Operating expenses 62.1 58.6 6% 189.5 180.6 5% 245.3
EBITA 40.6 28.0   83.4 68.0   94.2
% of net sales 24.9 18.2   18.5 15.7   15.8
Operating result (EBIT) 38.8 25.7   77.8 60.5   85.1
% of net sales 23.8 16.7   17.2 13.9   14.3
Result before taxes 38.3 24.2   75.2 53.8   77.1
Result for the period 29.0 18.6   57.4 41.5   59.8
Earnings per share 0.80 0.51 56% 1.58 1.14 38% 1.65
Return on equity, %       22.3 18.0   18.8
Research and development costs 16.6 14.6 14% 53.5 49.4 8% 68.3
Capital expenditure* 1.9 5.0 -63% 8.7 16.0 -45% 21.4
Depreciation, amortization and impairment 6.8 7.0 -4% 20.0 21.0 -5% 27.7
Cash flow from operating activities 35.6 25.8 38% 84.4 58.9 43% 90.4
Cash conversion 0.9 1.0   1.1 1.0   1.1
Net debt       -20.0 38.0   14.3
Gearing, %       -5.5 12.4   4.4

*Excluding impact of acquired businesses

President and CEO Kai Öistämö

“Vaisala had an excellent third quarter of 2026, with record high order intake, solid net sales growth, and very strong profitability. Industrial Measurements once again performed exceptionally, driving the group’s overall results. Weather, Energy, and Environment achieved very strong order intake, and Xweather continued to grow steadily.

Vaisala’s order intake increased by 38% in the third quarter, supported by growth in both Industrial Measurements and Weather, Energy, and Environment. Net sales increased by 6%, driven by very strong Industrial Measurements. Industrial Measurements’ growing share of Vaisala’s net sales also improved the group’s profitability, resulting in very strong EBITA. EBITA was further supported by U.S tariff refunds from 2025 as a one-off item in the third quarter. The group’s EBITA margin reached a record-high 24.9%. The order book increased to EUR 215.0 million, representing a 16% rise from the end of 2025.

The Industrial Measurements business area continued its very strong performance, as it has shown throughout the year. Order intake increased by 24%, with growth across regions and market segments. The business area’s net sales increased by 28% year over year. Record-high net sales in the quarter were supported by a strong opening order book at the start of the third quarter. Growth in both order book and net sales was driven by strong demand from the data center, semiconductor, battery manufacturing, and power industries. We continued to develop our offering for growth markets with new a monitoring solution and service portfolio for data centers. We also introduced a new dew point instrument for emerging and established industrial applications, including hydrogen and renewable gases.

The Xweather business area continued to grow in the third quarter, with net sales increasing by 9% year over year. Growth was driven particularly by the insurance industry, as well as by sales to developers and API customers. The acquisition of Atmo, Inc., announced in the second quarter, has progressed as planned, and we expect the transaction to close in the fourth quarter.

The Weather, Energy, and Environment business area achieved excellent order intake in the third quarter, increasing 53% year over year. The growth was boosted by the EUR 25 million order for airport weather systems and equipment in Indonesia, which was confirmed in September. The project, Vaisala’s largest aviation weather project to date, is now entering the implementation phase, with most of the delivery expected to take place over the next three years. As expected, Weather, Energy and Environment’s net sales were below last year’s level (11% decrease), against a very strong comparison period in 2025.

With the continued strong performance of Industrial Measurements driving growth in Vaisala’s net sales and profitability, and U.S. tariff refunds further supporting profitability, we adjusted our 2026 net sales estimate and raised our EBITA estimate. In our updated business outlook, announced on October 12, we estimate that our 2026 net sales will be in the range of EUR 610–630 million and our EBITA will be in the range of EUR 110–120 million. The business outlook excludes impacts of the planned Atmo, Inc. acquisition and potential significant changes in market conditions.”

Webcast and teleconference

A webcast and a conference call for analysts, investors, and media will be held in English on Tuesday, October 27, 2026, starting at 13:00 p.m. (EET).

You can participate in the live webcast via the following link: https://investorcaller.com/events/vaisala/vaisala-q3-report-2026

Questions may be presented by participating in the teleconference. You can access the teleconference by registering at the link below. After registration, you will receive an email with the dial-in numbers and a conference ID.
https://investorcaller.com/events/vaisala/vaisala-q3-report-2026   

A recording will be available at vaisala.com/investors later the same day.

Further information
Niina Ala-Luopa, investor relations
+358 400 728 957, ir@vaisala.com
Vaisala Corporation

Distribution
Nasdaq Helsinki
Key media
vaisala.com

Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With over 90 years of innovation and expertise, we employ a team of close to 2,500 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange. vaisala.com

Attachment

OP Pohjola
Interim Report 1 January–30 September 2026
Stock Exchange Release 27 October 2026 at 9.00 EET

OP Pohjola’s Interim Report for 1 January–30 September 2026: OP Pohjola’s operating profit was EUR 1,396 million – corporate loan portfolio grew by 10% year on year

  • Operating profit was EUR 1,396 million (1,715). Operating profit fell by 19%, or EUR 318 million year on year. The decrease was due to a decline in net interest income and income from investment activities, and an increase on OP bonuses and expenses.
  • Income from customer business, that is, net interest income, insurance service result and net commissions and fees in total increased to EUR 2,582 million (2,559). Insurance service result increased by 4% to EUR 188 million (181) and net commissions and fees rose by 16% to EUR 700 million (602). Net interest income decreased by 5% to EUR 1,695 million (1,776). Net interest income without OP bonuses earned by owner-customers decreased by 2% to EUR 1,925 million (1,961).
  • Impairment loss on receivables totalled EUR 36 million. A year ago, impairment loss on receivables reversed came to EUR 46 million. The ratio of impairment loss on receivables to loan and guarantee portfolio was 0.05% (-0.06). Non-performing exposures decreased, accounting for 1.9% (2.1) of total exposures.
  • Investment income fell to EUR 234 million (426).
  • Total expenses grew by 6% to EUR 1,829 million (1,725). The cost/income ratio weakened to 56% (51).
  • The loan portfolio grew year on year by 3% to EUR 103.2 billion (100.2). Deposits grew by 3% to EUR 82.0 billion (79.8). Year on year, the corporate loan portfolio grew by 10% to EUR 31.1 billion.
  • The CET1 ratio was 21.4% (21.2), which exceeds the minimum regulatory requirement by 7.2 percentage points.
  • The Retail Banking segment’s operating profit decreased by 16% to EUR 625 million (740). Net interest income decreased by 9% to EUR 1,212 million (1,334). Impairment loss on receivables totalled EUR 17 million. A year ago, impairment loss on receivables reversed came to EUR 7 million. Net commissions and fees increased by 15% to EUR 623 million (540). The cost/income ratio weakened to 65% (62). The loan portfolio grew to EUR 71.9 billion (71.5), while deposits increased by 3% year on year, to EUR 67.4 billion (65.6). Assets under management grew by 14% year on year to EUR 116.1 billion (101.8).
  • The Corporate Banking segment’s operating profit decreased by 25% to EUR 341 million (454). Net interest income decreased by 8% to EUR 409 million (445). Impairment loss on receivables came to EUR 20 million. A year ago, impairment loss on receivables reversed came to EUR 39 million. Net commissions and fees increased to EUR 80 million (64). The cost/income ratio weakened to 38% (34). The loan portfolio grew year on year by 10 % to EUR 31.5 billion (28.7). Deposits grew by 3% to EUR 15.2 billion (14.8).
  • Insurance segment’s operating profit grew by 14% to EUR 489 million (429). Insurance service result grew to EUR 188 million (181). Investment income increased to EUR 290 million (242). The combined ratio reported by non-life insurance improved to 87.5% (88.1).
  • The Group Functions segment’s operating loss was EUR -81 million (102). Income from investment activities, EUR -150 million (68), was decreased by changes in the fair value of equities.
  • OP Pohjola revamped its owner-customer benefits, effective as of 1 January 2026. New OP bonuses accrued to owner-customers increased by 29% to EUR 314 million (244). As of the beginning of 2026, OP bonuses were increased. They are also earned more widely from banking, wealth management and insurance services, and owner-customers can decide how to use them.
  • Outlook: Operating profit for 2026 is expected to be at a good level but lower than that for 2025. For additional information, see ‘Outlook’.

OP Pohjola’s key figures and ratios

€ million Q1–3/2026 Q1–3/2025 Change, % Q1–4/2025
Operating profit, € million 1,396 1,715 -18.6 2,269
Retail Banking 625 740 -15.6 912
Corporate Banking 341 454 -25.0 571
Insurance 489 429 14.1 590
Group Functions -81 102 — 199
New OP bonuses accrued to owner-customers, € million** -314 -244 28.7 -327
Total income 3,262 3,393 -3.9 4,639
Total expenses -1,829 -1,725 6.1 -2,424
Cost/income ratio, %* 56.1 50.8 5.3 52.2
Cost/income ratio, excluding OP bonuses, %* 51.2 47.5 3.6 49.0
Non-life Insurance combined ratio, %* 87.5 88.1 -0.6 87.7
Return on equity (ROE), %* 6.9 9.8 -2.9 9.5
Return on equity, excluding OP bonuses, %* 8.5 11.2 -2.6 10.9
Return on assets (ROA), %* 0.8 1.1 -0.3 1.1
Return on assets, excluding OP bonuses, %* 1.0 1.3 -0.2 1.3
  30 Sep 2026 30 Sep 2025 Change, % 31 Dec 2025
CET1 ratio, %* 21.4 21.0 0.5 21.2
Loan portfolio, € billion 103.2 100.2 3.0 100.4
Deposits, € billion 82.0 79.8 2.8 80.9
Assets under management, € billion 116.1 101.8 14.0 105.5
Ratio of non-performing exposures to exposures, %* 1.88 2.14 -0.26 2.06
Ratio of impairment loss on receivables to loan and guarantee portfolio, %* 0.05 -0.06 0.10 -0.05
Owner-customers (1,000) 2,144 2,132 0.5 2,136

Comparatives for the income statement items are based on the corresponding figures in 2025. Unless otherwise specified, figures from the end of 2025 are used as comparatives for balance-sheet and other cross-sectional items.
* Change in ratio, percentage point(s).
** Before withholding tax.

Comments by the President and Group CEO of OP Pohjola

OP Pohjola’s customer business continued to grow strongly in the third quarter

OP Pohjola’s customer business continued to grow strongly in the third quarter, and its credit risks were well managed. OP Pohjola’s operating profit for January–September was EUR 1,396 million. Customer business performed well in both the banking and insurance business. Income from customer business was EUR 2,582 million. The insurance service result increased by 4% year on year and net commissions and fees grew strongly, by 16%. Net interest income decreased by 5% compared to the same period in 2025. This was due to an increase in OP bonuses accrued to owner-customers. Excluding OP bonuses, net interest income decreased by only 1.8% year on year. Net interest income in the third quarter was 0.3% higher than in the previous year.

Expenses increased by 6% from the previous year, totalling EUR 1,829 million, mainly due to investments in ICT development and increased personnel costs. The cost/income ratio excluding OP bonuses was 51%.

The loan portfolio quality remained high, with non-performing exposures decreasing to 1.9% of total exposures. Impairment loss on receivables remained moderate: EUR 36 million was recognised in January–September. A year ago, impairment loss on receivables reversed came to EUR 46 million.

All three business segments performed well in January–September. The strongest performer was the Insurance segment with its earnings increasing to EUR 489 million thanks to a solid insurance service result and favourable development of income from investment activities. Retail Banking’s operating profit was EUR 625 million, and Corporate Banking’s operating profit was EUR 341 million.

OP Pohjola’s capital adequacy is very strong. At the end of September, OP Pohjola’s CET1 ratio was 21.4%, which exceeds the minimum regulatory requirement by 7.2 percentage points, that is, by EUR 5.9 billion. OP Pohjola is one of the most financially solid large banks in Europe. Our strong capital base and excellent liquidity form a solid foundation for serving our customers.

There has been a clear turnaround in the business environment this year

So far, the global economy has withstood the impacts of the Middle East War: in fact, macroeconomic indicators predict that growth will continue to accelerate slightly. However, the outlook remains uncertain, mainly due to developments in energy markets and inflationary pressures caused by rising energy prices. Growth in the euro area is expected to remain steady as manufacturing’s recovery and export demand offset hikes in interest rates and energy prices.

Finland’s economic growth accelerated to over 2% in Q3 of 2026. Exports have continued to grow well, investments have picked up and private consumption has begun to recover. Corporate confidence has grown stronger and the first positive signs have appeared on the labour market after a long downturn. In addition, consumers have more confidence in their finances and there has been an uptick in home-buying intentions.

However, interest rate hikes have impacted on the business environment. Both short and long-term interest rates have risen due to inflationary pressures. The most commonly used reference interest rate for home loans, the 12-month Euribor, was 3.33% at the end of September, compared to 2.24% at the end of 2025. On the other hand, Finland’s inflationary outlook remains more moderate than elsewhere in Europe. Price rises have mainly been fuelled by surging energy prices, whereas prices of other commodities have risen moderately. This is maintaining households’ purchasing power as real earnings grow, providing a strong basis for continued economic growth. We expect Finland’s economy to grow at 2% in 2026 and 2027. In addition to exports and investments, higher private consumption is expected to drive growth in 2027.

Households’ financial situation is good and confidence is growing

The economy’s gradual recovery is also reflected in household finances, whose stability is reflected in our customers’ good repayment capacity. Loan repayment capacity has remained extremely high among OP Pohjola’s customers. There was a further fall in the number of loan modification requests: these were 11% lower in January–September than in the same period in 2025. Furthermore, credit risks remained extremely low.

Strong household finances are also evident in deposits and lending. The deposit portfolio grew by 3% year on year, amounting to EUR 82 billion at the end of September. Household deposits have grown by 2% since 30 September 2025, to EUR 52 billion. OP Pohjola’s loan portfolio grew by 3% to EUR 103 billion compared to the same period last year. OP Pohjola is the clear market leader in deposits and credit in Finland. It has a market share of more than 40% in deposits and of over 39% in home loans.

Owner-customer membership is providing our customers with growing benefits

OP Pohjola’s mission is to promote the sustainable prosperity, security and wellbeing of its owner-customers and operating region. To support this goal, we renewed our owner-customer benefits in 2026 by increasing OP bonuses, expanding their accrual and giving customers more opportunities to decide how they are used. Our customers have warmly welcomed this reform.

Owner-customer membership eases the daily lives and finances of our customers at various times of life. New OP bonuses accrued to owner-customers increased by 29% year on year in January–September, totalling EUR 314 million. Although most of our owner-customers still use OP bonuses for banking and insurance services, an increasing number also use their OP bonuses for saving and investing. Besides OP bonuses, our owner-customers receive financial benefits on a daily basis, as well as a wide range of partner benefits that are easily accessible and usable on OP-mobile.

Our owner-customers also earn OP bonuses from home loans. The popularity of long-term home loans increased this year – a 30-year loan term is already being selected for 25% of new home loans. Longer loan terms bring smaller monthly instalments, which can add flexibility to household finances and enable saving and investment alongside loan repayments.

Saving and investing more active in Finland

Our customers’ choices are clear indications of growing interest in saving and investing. The number of mutual fund investors grew further, with 194,000 new mutual fund investment agreements being made in January–September. Our customers made new investments of EUR 3.3 billion in net terms, whereas assets under management grew to a record level of EUR 116 billion.

As well as helping people to start investing, we want to ease their first steps towards personal wealth creation. We therefore continue to offer OP First Investment – a EUR 100 investment in OP World Index fund – for babies born in Finland in 2027. More than 20,000 babies in Finland have received the investment since 2025 – a total of more than EUR 2 million had been invested for children by the end of August 2026. In other words, in the last couple of years almost a third of babies born in Finland have taken their first step in long-term saving and wealth building.

Companies’ appetite for growth is shaping demand for financing – the corporate loan portfolio grew by 10%

The economic recovery is raising companies’ appetite to invest and renew their businesses. Demand for corporate loans grew substantially in January–September: OP Pohjola’s corporate loan portfolio grew by 10% year on year, to EUR 31 billion. The amount of corporate loans drawn down at OP Pohjola grew by more than 31% compared to the same period in 2025.

Companies are actively seeking financing for investments, growth, internationalisation and upgrading of their operations. Based on its strong market position, broad regional network and diverse financing solutions, OP Pohjola will continue to support companies’ growth, investments and transformations throughout Finland. Accordingly, it is helping Finnish companies to grow and internationalise.

AI improves the customer experience

Generative AI is one of our key ways of developing our services and improving our customer experience. We already use AI in areas like customer service, processing of insurance compensation, anti-financial crime and supporting our personnel in their daily work.

Our AI-based app, OP Aina, has evolved into a personal digital assistant for customers, helping them to handle banking and insurance matters regardless of time and place. As well as answering customers’ questions, OP Aina helps them to anticipate and manage their daily finances by providing them with e.g. reminders, personal notifications and guidance.

In January–September, OP Aina had almost 8 million customer encounters, up by 36% year on year. OP Aina handled 3.9 million of all customer contacts and answered 22% of queries made by customers through various service channels. Our customers were extremely satisfied with OP Aina: a record 86% of all feedback received was positive.

They use AI to expedite the help they need, leaving our personnel to focus on situations where personal advice generates most value for customers. We aim to build a more personal, proactive and smooth service experience for all our customers.

My warm thanks to all our customers for your trust in OP Pohjola in 2026. We aim to continue earning the confidence you place in us. I would also like to thank our employees and governing bodies for their excellent work.

Timo Ritakallio
President and Group CEO

January–September

Operating profit was EUR 1,396 million (1,715), down by 18.6% year on year. Income from customer business, that is, net interest income, net commissions and fees and insurance service result increased to EUR 2,582 million (2,559). The cost/income ratio weakened to 56.1% (50.8). Cost/income ratio excluding OP bonuses was 51.2% (47.5).

New OP bonuses accrued to owner-customers increased by 28.7% to EUR 314 million. At the beginning of 2026, OP bonuses were increased and the range of services that provide them was widened.

Net interest income decreased by 4.6% to EUR 1,695 million. Net interest income was decreased by OP bonuses accrued to owner-customers totalling EUR 230 million (185). Net interest income without OP bonuses earned by owner-customers decreased by 1.8% to EUR 1,925 million. Net interest income reported by the Retail Banking segment decreased by 9.1% to EUR 1,212 million and that by the Corporate Banking segment decreased by 8.0% to EUR 409 million. The loan portfolio grew by 3.0% to EUR 103.2 billion, year on year. Year on year, the corporate loan portfolio grew by 9.8% to EUR 31.1 billion. The deposit portfolio grew by 2.8% year on year, to EUR 82.0 billion. Household deposits increased by 2.3% year on year, to EUR 51.6 billion. New loans drawn down by customers during the reporting period totalled EUR 21.9 billion (19.3).

Impairment loss on receivables totalled EUR 36 million. A year ago, impairment loss on receivables reversed came to EUR 46 million. Final credit losses totalled EUR 55 million (69). At the end of the reporting period, loss allowance was EUR 658 million (677), of which management overlay accounted for EUR 32 million (58). Non-performing exposures decreased, accounting for 1.9% (2.1) of total exposures. Impairment loss on loans and receivables accounted for 0.05% (-0.06) of the loan and guarantee portfolio.

Net commissions and fees grew by 16.2% to EUR 700 million. During the comparison period, owner-customers got daily banking services without monthly charges. Net commissions and fees for payment services increased by EUR 70 million to EUR 249 million and those for mutual funds by EUR 32 million to EUR 169 million. The commission income of mutual funds is reduced by OP bonuses earned by owner-customers, totalling EUR 52 million (39).

The insurance service result grew to EUR 188 million (181). The insurance service result includes EUR 421 million (400) of operating expenses and EUR 32 million (12) of OP bonuses earned by owner-customers. Non-life insurance net insurance revenue, including the reinsurer’s share, decreased to EUR 1,342 million (1,345). Net claims incurred after reinsurers’ share decreased by 3.1% to EUR 761 million. The combined ratio reported by non-life insurance improved to 87.5% (88.1).

Investment income (net investment income, net insurance finance expenses and income from financial assets held for trading) decreased to EUR 234 million (426). Insurance’s net investment income together with net finance expenses describe investment profitability in the insurance business. The combined return on investments at fair value of OP Pohjola’s insurance companies was 3.1% (3.0). Income from investment activities was reduced by changes in the fair value of Group Functions’ equity investments and Insurance’s notes and bonds.

Net income from financial assets recognised at fair value through profit or loss, or notes and bonds, shares and derivatives, totalled EUR 1,674 million (904). Net income from investment contract liabilities totalled EUR -1,079 million (-435). Net insurance finance expenses totalled EUR 413 million (185).

In banking, net income from financial assets held for trading decreased to EUR 57 million (136) as a result of changes in the value of derivatives.

Other operating income totalled EUR 24 million (8). A year ago, a EUR 23 million valuation adjustment in patient insurance policies with full risk for own account decreased other operating income.

Total expenses grew by 6.1% to EUR 1,829 million. Personnel costs rose by 4.9% to EUR 854 million. The increase was affected by headcount growth and pay increases as well as the cancellation of the transfer of the EUR 20 million earnings-related supplementary pension liability a year ago. The number of personnel increased by almost 190 year on year, especially in positions of customer care and sales, risk management and compliance, and service development.

Depreciation/amortisation and impairment loss on PPE and intangible assets grew by 1.7% to EUR 94 million. Impairment loss totalled EUR 19 million (7). Other operating expenses increased by 8.2% to EUR 881 million. ICT costs totalled EUR 477 million (427). Development costs were EUR 335 million (302) and capitalised development expenditure EUR 28 million (40). Charges of financial authorities were EUR 4 million (1).

Income tax amounted to EUR 360 million (345). The effective tax rate for the reporting period was 25.8% (20.1). The deferred tax rate increased because deferred tax assets were not recognised for part of the decrease in the fair value of equities. It is not probable that the decrease in the fair value of all equities is used for tax purposes. Comprehensive income after tax totalled EUR 1,045 million (1,462).

Equity amounted to EUR 20.6 billion (19.7). Equity included EUR 3.0 billion (3.1) in Profit Shares, terminated Profit Shares accounting for EUR 0.2 billion (0.3).

OP Pohjola’s funding position and liquidity are strong. LCR was 167% (186) and NSFR was 127% (131).

Outlook

The Finnish economy is expected to grow faster in 2026 than in the previous year. Geopolitical uncertainty or the escalation of geopolitical crises may affect the capital markets and the economic environment of OP Pohjola and its customers.

OP Pohjola’s operating profit for 2026 is expected to be at a good level but lower than that for 2025.

The main uncertainties affecting OP Pohjola’s earnings performance are associated with developments in the business environment, the capital market and developments in impairment loss on receivables. Forward-looking statements expressing the management’s expectations, beliefs, estimates, forecasts, projections and assumptions are based on the current view on developments in the economy, and actual results may differ materially from those expressed in the forward-looking statements.

Press conference

OP Pohjola’s financial performance will be presented to the media by President and Group Chief Executive Officer Timo Ritakallio in a press conference on 27 October 2026 at 11 am at Gebhardinaukio 1, Vallila, Helsinki.

Media enquiries: OP Corporate Communications, tel. +358 10 252 8719, viestinta@op.fi

OP Corporate Bank plc and OP Mortgage Bank plc will publish their own Interim Reports.

Financial reporting

Schedule for financial reports for 2026:

OP Amalgamation Pillar 3 Disclosures 30 September 2026 Week 46
   
Financial Statements Bulletin for 1 January‒31 December 2026 10 February 2027
Report by the Board of Directors (incl. Sustainability Report) and Financial Statements 2026 Week 11, 2027
OP Pohjola’s Annual Report 2026 Week 11, 2027
OP Pohjola’s Corporate Governance Statement 2026 Week 11, 2027
OP Pohjola’s Remuneration Report for Governing Bodies 2026 Week 11, 2027
Remuneration Policy for Governing Bodies at OP Pohjola Week 11, 2027
OP Amalgamation Pillar 3 Disclosures 2026 Week 11, 2027

Schedule for financial reports for 2027:        

Interim Report 1 January–31 March 2027 29 April 2027
Half-year Financial Report 1 January–30 June 2027 28 July 2027
Interim Report 1 January–30 September 2027 28 October 2027
   
OP Amalgamation Pillar 3 Disclosures 31 March 2027 Week 18
OP Amalgamation Pillar 3 Disclosures 30 June 2027 Week 32
OP Amalgamation Pillar 3 Disclosures 30 September 2027 Week 44

Helsinki, 27 October 2026

OP Cooperative
Board of Directors

For additional information, please contact:

Timo Ritakallio, President and Group CEO, tel. +358 10 252 4500
Mikko Timonen, Chief Financial Officer, tel. +358 10 252 1325
Piia Kumpulainen, Chief Communications Officer, tel. +358 10 252 7317

DISTRIBUTION:
Nasdaq Helsinki Ltd
Euronext Dublin (Irish Stock Exchange)
London Stock Exchange
Major media
op.fi

OP Pohjola is Finland’s largest financial services group, with more than two million owner-customers and approximately 15,000 employees. We provide a comprehensive range of banking and insurance services for personal and corporate customers. OP Pohjola consists of OP cooperative banks, its central cooperative OP Cooperative, and the latter’s subsidiaries and affiliates. Our mission is to promote the sustainable prosperity, security and wellbeing of our owner-customers and operating region. Together with our owner-customers, we have been building Finnish society and a better future for more than 120 years.

The Management Board of AS Pro Kapital Grupp (registration code 10278802, hereinafter the Company) convenes the extraordinary general meeting of the shareholders, which shall take place on Thursday, 26th of November 2026, starting at 13:00 (11:00 UTC), at the location of the Company, Sõjakooli 11, Tallinn. Registration of the participants of the meeting shall begin on the 26th of November 2026 at 12:45 and end at 13:00 at the location of the meeting.

The reason for convening the extraordinary general meeting is the recalling of one Supervisory Council member of the Company and election of one new Supervisory Council member. The agenda of the extraordinary general meeting is as follows:

  1. Election of the Chairman and Secretary of the extraordinary general meeting

To elect Andrus Laurits as the Chairman of the extraordinary general meeting. To elect the Secretary as per suggestions made at the extraordinary general meeting.

  1. Recalling of a Supervisory Council member and election of a new member

The members of the Supervisory Council have been elected until 5th of July 2029 (inclusive). Supervisory Council member Patrick Jacques Bernard Werner has tendered his resignation. The Management Board of the Company is proposing to the general meeting of shareholders to recall one Supervisory Council member and in his stead elect a new Supervisory Council member.

The Council’s and Management Board’s proposal and draft of the resolution:

  1. To recall Patrick Jacques Bernard Werner from the Supervisory Council of the Company, effective from the adoption of this resolution.
  2. To elect Paolo Ortolani (born 23 August 1993) as a new member of the Supervisory Council of the Company, whose powers shall commence upon the adoption of this resolution and last until 5th of July 2029 (inclusive).

The CV of the member of the Supervisory Council of the Company can be accessed on the homepage of the Company www.prokapital.com sub-section “Investor”.

Administrative issues:
According to the Commercial Code § 297 section 5, the set of shareholders entitled to take part in the extraordinary general meeting shall be determined seven calendar days prior to the general meeting as at the end of the working day of the settlement system of the registrar of the Estonian register of securities or another depository where the shares of the public limited company are entered, i.e. as at 19 November 2026, at the end of the working day.

A shareholder has the right to receive information on the activities of the public limited company from the management board at the extraordinary general meeting. The management board may refuse to give information if there is a basis to presume that this may cause significant damage to the interests of the public limited company. If the management board refuses to give information, the shareholder may demand that the general meeting of shareholders decide on the legality of the shareholder’s request, or file a petition to a court in proceedings on petition, within two (2) weeks after the general meeting, to oblige the management board to give information.

Without prior inclusion on the agenda, the extraordinary general meeting may decide on calling the next meeting, settle administrative issues related to the agenda and submissions concerning the procedure for holding the meeting, and discuss other matters without making resolutions.

Shareholders whose shares represent at least 1/20 of the share capital may submit to the public limited company a draft resolution for each item on the agenda at least 3 days before the extraordinary general meeting, i.e. on 23 November 2026 at the latest. The respective draft must be submitted in writing at the address of the Company: Sõjakooli 11, Tallinn, 11316.

Before the extraordinary general meeting, the shareholder can inform the Company of appointing a representative or of renouncing the power of attorney given to a representative, by sending a relevant digitally signed notice to the e-mail address prokapital@prokapital.com or by delivering a relevant notice in a format which can be reproduced in writing to the office of the Company at Sõjakooli 11, Tallinn, by 25th of November 2026 at 16:00 at the latest.

The shareholders of the Company can acquaint themselves with the proposals and drafts of the resolutions of the extraordinary general meeting and the CV of the Supervisory Council member on the webpage of the Company www.prokapital.com under the sub-section Company, Investor, Shareholder or, upon prior notice, at an agreed time on business days between 09:00 and 17:00 at the office of the Company at Sõjakooli 11, Tallinn. If you have any questions regarding the meeting, please contact us by phone +372 6 144 920 or by e-mail at prokapital@prokapital.com. Questions and answers related to the agenda of the shareholders’ meeting shall be published on the webpage of the Company www.prokapital.com under the sub-section Company, Investor, Shareholder.

Documents needed to participate in the meeting:
Shareholders who are natural persons are kindly asked to present a valid identification document. Shareholders who are legal entities are kindly asked to present a valid extract from the registry card (or another similar document) from the relevant register where that legal person has been registered, and a valid identification document of the representative. In addition to the documents mentioned above, representatives of shareholders who are natural persons as well as of shareholders who are legal entities must present a written power of attorney issued by the represented person. Documents issued by a foreign country’s official must be either legalized or authenticated with a document certificate apostille and translated into English.

Voting prior to the meeting (by form):
It is possible to vote on the items of the agenda in advance. The form with instructions is available on the webpage of the Company www.prokapital.com under the sub-section Company, Investor, Shareholder.

Best regards,
Management Board of AS Pro Kapital Grupp

Attachment

Bang & Olufsen A/S has, pursuant to the Danish Capital Markets Act, received a major shareholder notification from UBS Group AG.

  • As per 21 October 2026, UBS Group AG’s holding of shares and voting rights pursuant to section 38 of the Danish Capital Markets Act, as well as other financial instruments pursuant to section 39(2), was below 5 percent of the total share capital and voting rights in Bang & Olufsen A/S.

As of 21 October 2026, UBS Group AG held a total of 6,867,577 shares and voting rights in Bang & Olufsen A/S, corresponding to 4.66 percent of the total share capital and voting rights.

For further information, please contact:

Cristina Rønde Hefting
Sr. Director, Head of Strategy & Investor Relations

Attachment

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.